Mechanisms regulating autophagy in alcohol-induced liver injury

酒精性肝损伤中自噬的调节机制

基本信息

  • 批准号:
    8161101
  • 负责人:
  • 金额:
    $ 33.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-01 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Autophagy is a genetically programmed, evolutionarily conserved process that degrades long-lived cellular proteins and damaged organelles, including mitochondria, as a critical cell survival mechanism in response to stress. We recently reported that ethanol induces autophagy, which reduces ethanol-induced liver injury (Ding et al., 2010a). This is an important finding because alcohol abuse is a major cause of liver disease and a major health problem in the United States. Oxidative stress and mitochondrial damage play important roles in alcohol-induced hepatotoxicity. Cells may protect themselves by removing damaged mitochondria by mechanisms such as autophagy. Therefore modulating the autophagy process could offer new therapeutic treatments for alcoholic liver diseases. However, the mechanisms by which ethanol induces autophagy and how autophagy protects against ethanol-induced liver pathogenesis are not clear. Without such understanding, the potential to ultimately use autophagy in the treatment of alcohol-related liver disease will be limited. Our preliminary studies suggest that the forkhead transcription factor FoxO3a could play a major role in ethanol- induced autophagy. Therefore, the central hypothesis is that ethanol induces autophagy by activating FoxO3a, and autophagic removal of ethanol-induced damaged mitochondria is crucial to protect against ethanol- induced liver pathogenesis. To examine our hypothesis, three specific aims are proposed: 1) determine the mechanisms by which ethanol activates FoxO3a in hepatocytes, 2) determine how ethanol-activated FoxO3a induces autophagy in hepatocytes, and 3) determine the mechanisms by which removal of damaged mitochondria protects against ethanol-induced hepatotoxicity. The research proposed in this application is innovative in the concept that ethanol can activate autophagy as a protective mechanism against its known detrimental effects on the liver. Moreover, we will utilize novel genetic animal models such as GFP-LC3 transgenic and Atg5 liver-specific knockout mice to specifically study the role of autophagy in alcohol-induced liver injury. Furthermore, it focuses on the role of FoxO3a-mediated autophagy pathway in alcoholic liver disease, which has not been studied. The proposed research is significant because the results from this study will lead to the understanding of mechanisms and roles of autophagy in alcohol-induced liver pathogenesis. Ultimately, such knowledge has the potential of offering novel therapeutic approaches for treating alcoholic liver pathogenesis by modulating autophagy. PUBLIC HEALTH RELEVANCE: Alcohol abuse and consumption are major causes of liver disease and is a major health problem in the United States and around the world. Autophagy has been shown to be able to regulate mitochondria homeostasis and cell death, which are important in alcoholic liver disease. Elucidating the molecular mechanisms of how autophagy, mitochondria homeostasis and cell death are integrated in alcoholic liver disease will help to generate novel therapeutic strategies.
描述(由申请人提供):自噬是一种遗传编程的、进化上保守的过程,其降解长寿命的细胞蛋白和受损的细胞器,包括线粒体,作为响应应激的关键细胞存活机制。我们最近报道了乙醇诱导自噬,其减少乙醇诱导的肝损伤(Ding等人,2010年a)。这是一个重要的发现,因为酗酒是导致肝脏疾病的主要原因,也是美国的一个主要健康问题。氧化应激和线粒体损伤在酒精性肝毒性中起重要作用。细胞可以通过自噬等机制清除受损的线粒体来保护自己。因此,调节自噬过程可以为酒精性肝病提供新的治疗方法。然而,乙醇诱导自噬的机制以及自噬如何保护乙醇诱导的肝脏发病机制尚不清楚。如果没有这样的理解,最终使用自噬治疗酒精相关肝病的潜力将受到限制。我们的初步研究表明,叉头转录因子FoxO 3a可能在乙醇诱导的自噬中起主要作用。因此,中心假设是乙醇通过激活FoxO 3a诱导自噬,并且乙醇诱导的受损线粒体的自噬去除对于防止乙醇诱导的肝脏发病至关重要。为了检验我们的假设,提出了三个具体的目标:1)确定乙醇激活肝细胞中FoxO 3a的机制,2)确定乙醇激活的FoxO 3a如何诱导肝细胞自噬,3)确定去除受损线粒体保护乙醇诱导的肝毒性的机制。本申请中提出的研究在乙醇可以激活自噬作为其对肝脏已知有害影响的保护机制的概念上是创新的。此外,我们将利用新型遗传动物模型,如GFP-LC 3转基因和Atg 5肝脏特异性敲除小鼠,专门研究自噬在酒精诱导的肝损伤中的作用。此外,它集中在FoxO 3a介导的自噬途径在酒精性肝病中的作用,尚未研究。这项研究具有重要意义,因为这项研究的结果将有助于了解自噬在酒精诱导的肝脏发病机制中的作用和机制。最终,这些知识有可能提供新的治疗方法,通过调节自噬来治疗酒精性肝发病机制。 公共卫生相关性:酒精滥用和消费是肝脏疾病的主要原因,是美国和世界各地的一个主要健康问题。自噬已被证明能够调节线粒体稳态和细胞死亡,这在酒精性肝病中是重要的。阐明自噬、线粒体稳态和细胞死亡如何整合在酒精性肝病中的分子机制将有助于产生新的治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wen-Xing Ding其他文献

Wen-Xing Ding的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wen-Xing Ding', 18)}}的其他基金

Novel mechanisms of regulating endoplasmic reticulum homeostasis in alcoholic pancreatitis
调节酒精性胰腺炎内质网稳态的新机制
  • 批准号:
    10742433
  • 财政年份:
    2023
  • 资助金额:
    $ 33.75万
  • 项目类别:
Mechanisms regulating autophagy in alcohol-induced liver injury
酒精性肝损伤中自噬的调节机制
  • 批准号:
    10468416
  • 财政年份:
    2022
  • 资助金额:
    $ 33.75万
  • 项目类别:
Mechanisms regulating autophagy in alcohol-induced liver injury
酒精性肝损伤中自噬的调节机制
  • 批准号:
    10612977
  • 财政年份:
    2022
  • 资助金额:
    $ 33.75万
  • 项目类别:
Mechanisms of Impaired Lysosomal Biogenesis and Autophagy in Alcohol-Associated Alzheimer's Disease
酒精相关阿尔茨海默氏病溶酶体生物发生和自噬受损的机制
  • 批准号:
    10266178
  • 财政年份:
    2020
  • 资助金额:
    $ 33.75万
  • 项目类别:
Mechanisms of Impaired Lysosomal Biogenesis and Autophagy in Alcohol-Associated Alzheimer's Disease
酒精相关阿尔茨海默氏病溶酶体生物发生和自噬受损的机制
  • 批准号:
    10630185
  • 财政年份:
    2020
  • 资助金额:
    $ 33.75万
  • 项目类别:
Mechanisms of Impaired Lysosomal Biogenesis and Autophagy in Alcohol-Associated Alzheimer's Disease
酒精相关阿尔茨海默氏病溶酶体生物发生和自噬受损的机制
  • 批准号:
    10405008
  • 财政年份:
    2020
  • 资助金额:
    $ 33.75万
  • 项目类别:
Prevention and treatment of ALD by inducing hepatic mitochondrial uncoupling
诱导肝线粒体解偶联防治ALD
  • 批准号:
    9761397
  • 财政年份:
    2018
  • 资助金额:
    $ 33.75万
  • 项目类别:
Autophagy in Alcoholic Pancreatitis
酒精性胰腺炎中的自噬
  • 批准号:
    9298263
  • 财政年份:
    2017
  • 资助金额:
    $ 33.75万
  • 项目类别:
Autophagy in Alcoholic Pancreatitis
酒精性胰腺炎中的自噬
  • 批准号:
    10189453
  • 财政年份:
    2017
  • 资助金额:
    $ 33.75万
  • 项目类别:
Autophagy in Alcoholic Pancreatitis
酒精性胰腺炎中的自噬
  • 批准号:
    9925046
  • 财政年份:
    2017
  • 资助金额:
    $ 33.75万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了